Keywords: c-myc; nPM / PM0.2; Nano-Scale Particulate Matter / Particulate Matter <â¯0.2â¯Âµm diameter; PM2.5; Particulate Matter <â¯2.5â¯Âµm diameter; Nrf2; Nuclear factor (erythroid-derived 2)-like 2; Bach1; BTB Domain And CNC Homolog 1; c-Myc; MYC proto-oncogene; TR
مقالات ISI c-myc (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: c-myc; α-SMA; α-smooth muscle actin; AIF; apoptosis inducing factor; AP-1; activator protein 1; ARE; antioxidant response element; Bax; Bcl-2 associated X protein; Bcl-2; B-cell lymphoma 2; Bcl-xl; B cell lymphoma extra large; CDKCs; cyclin:CDK complexes; c-My
Keywords: c-myc; BM; bone marrow; CCL; chemokine (C-C motif) ligand; c-MYC; avian myelocytomatosis virus oncogene cellular homolog; CX3CR1; CX3C chemokine receptor 1; GSK3-β; glycogen synthase kinase 3 beta; IC50; half-maximal inhibitory concentration; LIF; leukemia inhi
Keywords: c-myc; 5-FU; 5-Fluorouracil; ABCB5; ATP-binding cassette sub-family B member 5; ABCC2; ATP-binding cassette sub-family C member 2; ABCG2; ATP-binding cassette sub-family G member 2; ACs; Anthocyanins; ALDH; aldehyde dehydrogenase; AML; acute myeloid leukemia; AP
Keywords: c-myc; HIV; Cancer; c-Myc; hTERT; Burkitt's Lymphoma;
Keywords: c-myc; Axon regeneration; Optic nerve; Retinal ganglion cell; klf-4; Oncomodulin; Inflammation; pten; socs3; c-Myc; Optic chiasm; Lateral geniculate nucleus; Eye transplantation;
Keywords: c-myc; lncRNAs; CCAT1; CCAT2; c-MYC; Therapeutic target;
Keywords: c-myc; AT1R; angiotensin II receptor type 1; BMC; bone marrow cell and precursor; BMM; bone marrow-derived macrophage; C/EBPβ; CCAAT/enhancer binding protein beta; c-Myc; Avian myelocytomatosis virus oncogene cellular homolog; CSF; colony-stimulating factor; DM
Keywords: c-myc; Aurora kinase A; Histone H3; c-Myc; Cranio-caudal axis; Sarcoma-180;
Keywords: c-myc; Immunometabolism; Nutrient sensing; Glucose; Glutamine; Amino acids; SCFA; LCFA; Cholesterol; Oxysterols; Srebp; mTORC1; c-Myc; GCN2; Slc7a5; CD36; LXR; Glycolysis; OxPhos; Lymphocyte; Macrophage;
Keywords: c-myc; 3-AP; 3-aminopyridine-2-carboxaldehyde thiosemicarbazone; ATM; ataxia telangiectasia mutated; ATR; ataxia telangiectasia and Rad3-related protein; AMP/ADP/ATP; adenosine mono-, di-, and tri-phosphate; BLM; Bloom syndrome RecQ helicase-like; BRAF; V-raf mu
Keywords: c-myc; BRET; bioluminescence resonance energy transfer; CHTN; cooperative human tissue network; c-myc; cellular proto-oncogene related to myelocytomatosis viral oncogene; Î; delta - meaning without; DPBS; Dulbecco's phosphate buffered saline; E2; estrogen:17-
Keywords: c-myc; Autophagy; Protein disulfide isomerase; Microenvironment; Nitazoxanide; c-Myc; Glutathione S-transferase; Interleukin 6
Keywords: c-myc; RNA; ribonucleic acid; PCR; polymerase chain reaction; cDNA; complementary deoxyribonucleic acid; TIMP1; Tissue Inhibitor of Metalloproteinase I; c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; SPARC; secreted protein acidic and rich in cystei
Keywords: c-myc; FASD; fetal alcohol spectrum disorder; FAS; fetal alcohol syndrome; pFAS; partial fetal alcohol syndrome; ARND; alcohol-related neurodevelopmental disorder; GD-7; gestational day 7; GABA; γ-amino-butyric acid; PET; position emission tomography; PV; parva
Keywords: c-myc; Nodal; Breast cancer; p27; c-myc; ERK;
Keywords: c-myc; Diarylacetylenes; Colon cancer; Antineoplastic agents; c-myc;
Keywords: c-myc; Autocrine human growth hormone; Arsenic trioxide; Mammary adenocarcinoma; Breast cancer; c-Myc; Apoptosis;
Keywords: c-myc; Oxaliplatin; Cold allodynia; TRPM8; c-Myc
LncRNA HOXA-AS2 and its molecular mechanisms in human cancer
Keywords: c-myc; lncRNA; HOXA-AS2; Diagnosis; Therapeutic target; Prognosis; APL; Acute promyelocytic leukemia; ATRA; All trans retinoic acid; Bax; BCL2-Associated X; BC; Breast cancer; Bcl-2; B-cell lymphoma-2; c-Myc; MYC proto-oncogene; CRC; Colorectal cancer; DDIT3; DN
Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women
Keywords: c-myc; p27; c-Myc; Cyclin and cyclin dependent kinase; Axin I tumor suppressor gene; Triple negative breast cancer; African American;
Esculetin Attenuates the Growth of Lung Cancer by Downregulating Wnt Targeted Genes and Suppressing NF-κB
Keywords: c-myc; Esculetin; Lung cancer; Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB); C-myc; Cyclin D1; Esculetina; Cáncer de pulmón; Factor nuclear potenciador de las cadenas ligeras kappa de células B activadas (NF-κB); C-myc; Ciclina D1;
Overexpression of lncRNA DANCR positively affects progression of glioma via activating Wnt/β-catenin signaling
Keywords: c-myc; DANCR; Proliferation; β-catenin; c-myc; Glioma;
Functional characterization of grass carp runt-related transcription factor 3: Involvement in TGF-β1-mediated c-Myc transcription in fish cells
Keywords: c-myc; Grass carp; Runx3; TGF-β1; c-Myc; Transcription regulation;
Cell survival regulation during receptor-mediated endocytosis of chemically-modified lipoproteins associated to the formation of an Amphiphysin 2 (Bin1)/c-Myc complex
Keywords: c-myc; Bin1/Amphiphysin; c-Myc; Oxidative stress; Lipoprotein internalization; Cell survival;
Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer
Keywords: c-myc; eIF4E; Ribavirin; VEGF; c-Myc; Chemoresistance; Cancer therapy;
Oncogenic MicroRNA-20a is downregulated by the HIF-1α/c-MYC pathway in IDH1 R132H-mutant glioma
Keywords: c-myc; IDH1 mutation; Glioma; HIF-1α; c-MYC; miR-20a;
HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc
Keywords: c-myc; Prostate cancer; HUWE1; c-Myc; Cancer proliferation; Migration; Explant;
Cross talk between TP53 and c-Myc in the pathophysiology of Diamond-Blackfan anemia: Evidence from RPL11-deficient in vivo and in vitro models
Keywords: c-myc; Diamond-Blackfan anemia; Ribosomopathy; TP53; c-Myc; Zebrafish; RPL11;
microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4
Keywords: c-myc; Hepatocellular carcinoma; BRD4; microRNA-608; c-Myc; Cell growth;
Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1
Keywords: c-myc; Octreotide; Cyclin D1; C-Myc; Hepatic fibrosis; α-SMA; Wnt/β-catenin;
Antimony enhances c-Myc stability in prostate cancer via activating CtBP2-ROCK1 signaling pathway
Keywords: c-myc; Antimony; CtBP2; c-Myc; Cell proliferation; Prostate cancer;
Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer
Keywords: c-myc; Myo1b; Cervical cancer; Human papillomavirus 16 (HPV16); MMP1; MMP9; c-MYC;
Long non-coding RNA PVT1 as a novel candidate for targeted therapy in hematologic malignancies
Keywords: c-myc; Long non coding RNA; PVT1; Targeted therapy; c-Myc; Leukemia;
Flavonoids Luteolin and Quercetin Inhibit RPS19 and contributes to metastasis of cancer cells through c-Myc reduction
Keywords: c-myc; Luteolin; Quercetin; c-Myc; RPS19; EMT;
c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach
Keywords: c-myc; c-MYC; G-quadruplex; BMH-21; Antitumor agents; NMR; Molecular modelling;
Hsa-miR-11181 regulates Wnt signaling pathway through targeting of APC2 transcripts in SW480 cell line
Keywords: c-myc; Wnt; wingless-type; APC; adenomatosis polyposis coli; Axin; axis inhibition protein; FZ; frizzled; LEF; lymphoid enhancer binding factor; TCF; T-cell-specific factor; GSK3-β; glycogen synthase kinase 3-beta; TRE; transcriptional response element; Dsh; di
Gene therapy with antisense oligonucleotides silencing c-myc reduces neointima formation and vessel wall thickness in a mouse model of vein graft disease
Keywords: c-myc; Coronary artery bypass grafting; Vein graft disease; Mouse model; Gene therapy; Antisense oligonucleotides; C-myc;
EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes
Keywords: c-myc; Proliferation center; CLL/SLL; EZH2; miR-26a; C-myc;
RvD1 inhibits TNFα-induced c-Myc expression in normal intestinal epithelial cells and destabilizes hyper-expressed c-Myc in colon cancer cells
Keywords: c-myc; Resolvin D1; Colitis-associated cancer; c-Myc; Resolution of inflammation; Colon cancer;
LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma
Keywords: c-myc; PDIA3P; c-Myc; Multiple myeloma; Drug resistance; G6PD; Pentose phosphate pathway;
Therapeutic management of peritoneal ascitic sarcomatosis by Ruta graveolens: A study in experimental mice
Keywords: c-myc; Peritoneal sarcomatosis; Chemotherapy; c-Myc; Chk2; CD 95;
Camptothecin enhances c-Myc-mediated endoplasmic reticulum stress and leads to autophagy by activating Ca2+-mediated AMPK
Keywords: c-myc; Autophagy; Camptothecin; c-Myc; Endoplasmic reticulum stress; Reactive oxygen species;
Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics
Keywords: c-myc; Cancer stem cells; Biomarkers; Therapeutic target; Prostate cancer; Gene expression; ALDH1; Aldehyde Dehydrogenase 1; BMP2; Bone Morphogenetic Protein 2; CD133; Prominin-1; c-Myc; MYC Proto-Oncogene; CICs; cancer initiating cells; CSC; cancer stem cell; C
Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction
Keywords: c-myc; Deferoxamine (DFO); Esophageal squamous cell carcinoma (ESCC); ERK1/2; Mitochondria; Cellular bioenergetics; c-Myc;
Notch1 activation enhances proliferation via activation of cdc2 and delays differentiation of myeloid progenitors
Keywords: c-myc; Notch1; MAML; cdc2; c-Myc; PU.1; Myeloid progenitor cells;
Up-regulation of INSR/IGF1R by C-myc promotes TSCC tumorigenesis and metastasis through the NF-κB pathway
Keywords: c-myc; INSR, IGF1R; Tumorigenesis; Metastasis; NF-κB pathway; C-myc; Tongue squamous cell carcinoma;
Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy
Keywords: c-myc; A2058; human metastatic melanoma cell; A2780; human ovarian carcinoma cell; A2780cisR; cisplatin-resistant A2780; A375; human melanoma cell; A549; human lung adenocarcinoma epithelial cell; A549R; cisplatin-resistant A549 cell; Aβ; beta-amyloid; acac; ac
Effects on tubulin polymerization and down-regulation of c-Myc, hTERT and VEGF genes by colchicine haloacetyl and haloaroyl derivatives
Keywords: c-myc; Tubulin; Colchicine; Microtubules; Polymerization; Cell cycle; c-Myc; hTERT; VEGF; Oncogene;
Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand
Keywords: c-myc; CDCA; chenodeoxycholic acid; CA; cholic acid; DCA; deoxycholic acid; LCA; litocholic acid; BAs; bile acids; BARS; bile acid activated receptors; GPBAR1; G protein coupled bile acid receptor; TGR5; Takeda G protein receptor 5; FXR; farnesoid x-receptor; PX